For pharma stakeholders, the message is clear: the obesity and diabetes drug market is not just a therapeutic opportunity, but a strategic growth engine for the next decade.
& Hatipoglu, B
A patient who loses 30 pounds on Wegovy loses roughly ten pounds of lean tissue
Early trials in the 2000s did not show meaningful weight loss versus placebo, and it never received FDA approval for that use
Koeth RA, Wang Z, Levison BS, Buffa JA, Sheehy BT, Britt EB, Fu X, Wu Y, Li L, Smith JD, DiDonato JA, Chen J, Li H, Wu GD, Lewis JD, Warrier M, Brown JM, Krauss RM, Tang WH, Bushman FD, Lusis AJ, Hazen SL: Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis
However, not all of these medications are as effective as Semaglutide